None listed
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
Dr. Priyamvada Singh
Eligibility
Inclusion criteria
Inclusion criteria: 1.Individuals with age more than 18 years with type 2 diabetes mellitus as per the ADA criteria 2.Patients on treatment for type 2 diabetes mellitus.
Exclusion criteria
Exclusion criteria: 1.Individuals less than 18 years or above 80 years. 2.Clinical evidence of peripheral vascular disease ( absent peripheral pulses, skin changes, gangrene and symptoms of claudication). 3.Patients who have received chemotherapy in the past. 4.Patients with history of smoking more than or equal to 10 pack years. 5.Alcohol use disorder diagnosed as per the CAGE questionnaire. 6.Any known underlying autoimmune disorder. 7.HBV, HCV or HIV serology positive. 8.Patients with history of amputation. 9.Patients on drugs affecting sympathetic activity (such as clonidine, amphetamines, beta blockers, beta 2 agonists, alpha blockers, beta 3 adrenergic agonists) daily intake for a duration of 5-10 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the efficacy of Sudoscan in detecting early small fibre neuropathy in diabetic patients grouped as having the disease for less than and more than or equal to 5 yearsTimepoint: Baseline (at the time of participant enrollment) single time assesment only. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome measure will also be to compare the results with the standard NCS. The results will then be compared with the clinical assessment using the MNSI.Timepoint: Baseline (at the time of participant enrollment) single time assesment only. | — |
Countries
India
Contacts
Public ContactDr Priyamvada Singh
Kasturba Medical college, Manipal
Outcome results
None listed